TONIX PHARMACEUTICALS HOLDIN
TNXPNASDAQ๐ #3994 by market capEarnings Nov 9US Equity
$5.37โผ $0.02 (โ0.37%)
๐
Pre-market$5.40โฒ 0.56%Regular close ยท extended-hours price shownTrack TNXP
Get earnings, price moves & breaking news on Telegram
24hโผ 0.4%
7dโ
14dโ
30dโ
ytdโ
1yโ
๐ฆMarket Cap
$92M
Small Cap
๐Revenue Growth (YoY)
29.9%
High Growth
๐Gross Margin
80.3%
High
๐ตFCF Margin
-549.4%
Thin
โ๏ธP/S Ratio
3.2x
Fair
Otter Score
โ
Insufficient data
TONIX PHARMACEUTICALS HOLDIN
TNXPAnalyst Ratings
Price
$5.37
Total
7
Raised
0
Lowered
2
Avg PT
$22.50
H / L
$27 / $18
| Institution | Action | Rating | Date | Upside | |
|---|---|---|---|---|---|
Noble Capital Markets | Reiterated | Outperform | 2025-03-20 | โ | โ |
Alliance Global Partners | Reiterated | Buy | 2024-07-22 | โ | โ |
B. Riley FBR | Downgraded | Buy โ Neutral | 2019-11-18 | โ | โ |
Roth Capital | Downgraded | Buy โ Neutral | 2019-11-18 | โ | โ |
Oppenheimer | Reiterated | Outperform | 2019-11-18 | โ | โ |
Cantor Fitzgerald | Reiterated | Buy | 2019-11-18 | โ | โ |
Janney Capital | Reiterated | Buy | 2015-05-07 | โ | โ |
Institution
Noble Capital Markets
Reiterated ยท Outperform ยท 2025-03-20
โ
โ
Alliance Global Partners
Reiterated ยท Buy ยท 2024-07-22
โ
โ
B. Riley FBR
Downgraded ยท Buy โ Neutral ยท 2019-11-18
โ
โ
Roth Capital
Downgraded ยท Buy โ Neutral ยท 2019-11-18
โ
โ
Oppenheimer
Reiterated ยท Outperform ยท 2019-11-18
โ
โ
Cantor Fitzgerald
Reiterated ยท Buy ยท 2019-11-18
โ
โ
Janney Capital
Reiterated ยท Buy ยท 2015-05-07
โ
โ
One row per institution ยท price target from the firm's latest published target